LifeSteps Financial’s Albemarle ALB Stock Holding History

LifeSteps Financial’s Portfolio ALB Stock Details ALB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-175	Closed	-$23.1K	–	94
2024 Q1	$23.1K	Buy	+175	New	+$21.5K	0.02%	218

Other funds holding ALB

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

LifeSteps Financial's ALB Position: Q2 2024 in Review

LifeSteps Financial sold out of Albemarle (ALB) in Q2 2024, closing a stake of 175 shares — an estimated $23.1K sold.

LifeSteps Financial first reported a position in ALB in Q1 2024 and held it in 1 quarter. The position peaked at $23.1K in Q1 2024. 843 funds tracked by Wall St. Rank hold ALB as of Q2 2024.

LifeSteps Financial reported no remaining Albemarle position as of Q2 2024 after selling out during the quarter.
LifeSteps Financial sold 175 Albemarle shares in Q2 2024, an estimated $23.1K.
LifeSteps Financial first reported a position in Albemarle in Q1 2024 and held it in 1 quarter.
LifeSteps Financial's Albemarle position peaked at $23.1K in Q1 2024.
843 funds tracked by Wall St. Rank held Albemarle as of Q2 2024.

Based on LifeSteps Financial's 13F filing for Q2 2024, filed 17 Jul 2024.